From sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.

Scientists identified key ways Ebola, Dengue, and Zika viruses hijack the body’s cells, and they found at least one potential drug that can disrupt this process in human cells.

Thirty-five years after its launch, Ward 86 continues to be a global leader in HIV care and has significantly influenced milestones in treatment and prevention.

UC San Francisco, National Jewish Health and Centro de Neumología Pediátrica in Puerto Rico have been awarded nearly $10 million to address the root causes of asthma in children in Puerto Rico.

The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.

Almost half of the nearly 10 million patients with active tuberculosis each year could potentially be cured with significantly shorter treatments than current guidelines recommend.

These results confirm that the HPV virus causes head and neck cancer by inactivating the same proteins that are mutated in smoking-induced cancer.

A group of researchers from the Gladstone Institutes, UCSF, and UC Berkeley used a systematic approach to get an entirely new look at the way tuberculosis infects people.